This is the authors' abstract. We don't add key points for this paper.
Background & Aims: Resistant starch (RS) is a form of starch that human digestive enzymes cannot access, and it is fermented in the lower intestinal tract, modifying microbiota and producing short-chain fatty acids.Although numerous studies have investigated the impact of RS on human health, its exact mechanisms and effects on human health and diseases are not yet fully understood.Materials & Methods: This review study was conducted using relevant keywords and electronic searches in Scopus, PubMed, and Web of Science databases.Results: Resistant starch type 2 (RS2), a high amylose starch (HAM-S), cannot be completely digested in the gastrointestinal tract due to its specific structure.Consequently, RS2 affects satiety, obesity, and other metabolic variables in a dose-dependent manner.Additionally, a diet rich in HAM-S may have beneficial effects on gastrointestinal health and kidneys by altering gut microbiota and reducing nitrogenous waste in the body.However, several studies have shown that the intake of high amylose supplements has no positive effects on cardiometabolic variables. Conclusion:This study reviewed some of the main effects of resistant starch type 2 (RS2) on obesity, gut health, chronic kidney diseases, and cardiometabolic health.Due to the beneficial effects of RS2 on human health and the absence of significant side effects from its consumption, it is probably helpful to consider HAM-S as part of daily carbohydrate intake.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heshmati et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: